| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | Aug 24, 2023 | Xenon Pharmaceuticals Inc. | Director | Sell | 20.0 | -25,000 | -50.00% | ✗ | $967.5K |
| Jun 9, 2022 | Jun 10, 2022 | PTC THERAPEUTICS, INC. | Director | Sell | 46.3 | -738 | -2.48% | ✗ | $20.1K |
| May 16, 2022 | May 18, 2022 | Adverum Biotechnologies, Inc. | Director | Buy | 91.3 | +30,000 | 150.00% | ✗ | $25.6K |
| Jan 7, 2022 | Jan 11, 2022 | PTC THERAPEUTICS, INC. | Director | Sell | 86.3 | +2,690 | 9.94% | ✗ | $19.6K |
| Jun 9, 2021 | Jun 11, 2021 | PTC THERAPEUTICS, INC. | Director | Sell | 46.3 | -365 | -1.33% | ✗ | $15.3K |
| Mar 31, 2021 | Apr 1, 2021 | Adverum Biotechnologies, Inc. | Director | Buy | 95.0 | +20,000 | 100.00% | ✗ | $200.3K |
| Feb 1, 2021 | Feb 2, 2021 | PTC THERAPEUTICS, INC. | Director | Sell | 46.3 | -506 | -1.81% | ✗ | $28.8K |
| Jun 11, 2020 | Jun 12, 2020 | PTC THERAPEUTICS, INC. | Director | Sell | 46.3 | -364 | -1.37% | ✗ | $17.6K |
| Aug 14, 2017 | Aug 15, 2017 | Xenon Pharmaceuticals Inc. | Director | Buy | 95.0 | +50,000 | 100.00% | ✗ | $140.8K |
| May 23, 2017 | May 24, 2017 | PTC THERAPEUTICS, INC. | Director | Buy | 97.5 | +25,000 | 100.00% | ✗ | $337.2K |